Search details
1.
Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report.
Lancet
; 402(10399): 397-410, 2023 07 29.
Article
in English
| MEDLINE | ID: mdl-37393920
2.
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
N Engl J Med
; 384(1): 31-41, 2021 01 07.
Article
in English
| MEDLINE | ID: mdl-33200890
3.
First-in-Human Phase 1 Randomized Trial with the Anti-CD40 Monoclonal Antibody KPL-404: Safety, Tolerability, Receptor Occupancy, and Suppression of T-Cell-Dependent Antibody Response.
J Pharmacol Exp Ther
; 387(3): 306-314, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37699709
4.
Preclinical Immunopharmacologic Assessment of KPL-404, a Novel, Humanized, Non-Depleting Antagonistic Anti-CD40 Monoclonal Antibody.
J Pharmacol Exp Ther
; 381(1): 12-21, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35078863
5.
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.
Ann Rheum Dis
; 81(4): 524-536, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35045965
6.
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis
; 81(5): 653-661, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35264321
7.
Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Exp Dermatol
; 30(6): 804-810, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33428793
8.
Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept.
BMC Cardiovasc Disord
; 21(1): 201, 2021 04 21.
Article
in English
| MEDLINE | ID: mdl-33882846
9.
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1ß trap, in patients with recurrent pericarditis.
Am Heart J
; 228: 81-90, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32866928
10.
Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716.
Acta Derm Venereol
; 100(14): adv00197, 2020 Jul 02.
Article
in English
| MEDLINE | ID: mdl-32374409
11.
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. Reply.
N Engl J Med
; 384(15): 1475-1476, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33852791
12.
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.
J Lipid Res
; 56(3): 703-712, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25561459
13.
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Circulation
; 130(2): 138-46, 2014 Jul 08.
Article
in English
| MEDLINE | ID: mdl-24895454
14.
The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.
Am Heart J
; 169(5): 736-742.e1, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25965722
15.
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial.
Eur Heart J
; 35(46): 3277-86, 2014 Dec 07.
Article
in English
| MEDLINE | ID: mdl-24780501
16.
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.
Stroke
; 45(5): 1304-12, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24743444
17.
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
N Engl J Med
; 365(10): 883-91, 2011 Sep 08.
Article
in English
| MEDLINE | ID: mdl-21830957
18.
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept.
J Am Heart Assoc
; 13(6): e032516, 2024 Mar 19.
Article
in English
| MEDLINE | ID: mdl-38471825
19.
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.
Heart
; 109(4): 297-304, 2023 01 27.
Article
in English
| MEDLINE | ID: mdl-36316102
20.
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor ß antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.
EClinicalMedicine
; 57: 101826, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36816342